Our goal is to ensure that patients gain timely access to our products, and thereby maximise their commercial value. As such, Ferrer seeks to establish alliances with strong local partners in countries where we do not operate directly. Today, Ferrer products are commercialised in more that 90 countries worldwide.
Ferrer is also seeking long-term partners for our portfolio of internal R&D programs, through development and licensing arrangements that accelerate market access and commercialisation in the major territories around the world (such as North America, Asia and the BRIC countries).
Ferrer: An experienced partner
In Ferrer, we prioritize and have extensive experience in the setting-up and consolidation of strategic alliances: with public bodies, emerging biotech companies, medium-size local companies and big multinationals. Together with a focussed sales and marketing organization, this positions us as a strong competitor against other licensees in the areas in which we operate.
Our specialised sales forces around the world, which benefit from continual scientific and sales training, ensure the highest level of promotion to health professionals.
Innovation, investment in the permanent development of our products and a proactive and creative approach to marketing further guarantee the success of our commercialised products.
Ferrer is involved in collaborative and open innovation projects with state-of-the-art academic institutions and start ups involved in breakthrough research. Our aim is to speed up the project development process in order to launch products on the market.
Ferrer’s philosophy and culture is focussed on establishing medium and long-term collaborations. This means that we offer our partners a real commitment to their products, treating them as we do our in-house projects.
Our flexible, fully-integrated organization ensures the efficient evaluation of opportunities for collaboration and expedites the negotiation and decision-making process.